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Abstract
Multifunctional envelope-type nanodevices (MENDs) are very promising non-viral gene delivery vectors because they are
biocompatible and enable programmed packaging of various functional elements into an individual nanostructured
liposome. Conventionally MENDs have been fabricated by complicated, labor-intensive, time-consuming bulk batch
methods. To avoid these problems in MEND fabrication, we adopted a microfluidic chip with a chaotic mixer array on the
floor of its reaction channel. The array was composed of 69 cycles of the staggered chaotic mixer with bas-relief structures.
Although the reaction channel had very large Pe ´clet numbers (.10
5) favorable for laminar flows, its chaotic mixer array led
to very small mixing lengths (,1.5 cm) and that allowed homogeneous mixing of MEND precursors in a short time. Using
the microfluidic chip, we fabricated a double-lamellar MEND (D-MEND) composed of a condensed plasmid DNA core and a
lipid bilayer membrane envelope as well as the D-MEND modified with trans-membrane peptide octaarginine. Our lab-on-a-
chip approach was much simpler, faster, and more convenient for fabricating the MENDs, as compared with the
conventional bulk batch approaches. Further, the physical properties of the on-chip-fabricated MENDs were comparable to
or better than those of the bulk batch-fabricated MENDs. Our fabrication strategy using microfluidic chips with short mixing
length reaction channels may provide practical ways for constructing more elegant liposome-based non-viral vectors that
can effectively penetrate all membranes in cells and lead to high gene transfection efficiency.
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Introduction
Gene therapy is an administration of genes within cells to treat
diseases by correcting defective genes that cause the diseases. It has
attracted great attention among scientific research, engineering,
and clinical application communities because of its huge potential
for effective treatments of various diseases ranging from congenital
genetic disorders to lifestyle diseases. In general, gene therapy
requires gene carriers, called gene delivery vectors (hereafter
referred to as ‘vectors’ for simplicity), to deliver genes within target
cells. Mainly two different types of vectors exist: viral and non-viral
vectors. Viral vectors, such as adenoviruses and retroviruses, offer
high gene transfection efficiency but they come with a high health
risk due to the inability to control their immunogenicity and
pharmacokinetics [1–3]. Non-viral vectors, represented by various
liposome and polymer vectors, can be designed with suppressed
toxicity and antigenicity by controlling their physical properties
but they have disadvantages of instability in the blood stream,
meager specificity toward targets, and low gene transfection
efficiency [1–4].
Recently non-viral vectors have gained much more attention
than viral vectors, despite their many problems-to-be-solved, due
to their relatively low health hazard, capability for drug delivery,
which is infeasible with viral vectors, and high potential for order-
made gene therapy [1–4]. Liposome-based non-vial vectors have
been especially attractive because liposomes are composed of
biological components which lead to their low toxicity and low
antigenicity; they can be metabolized in vivo; and they can
encapsulate enzymes and drugs inside themselves [3,5–9]. Many
investigations on liposome-based non-viral vectors have focused on
fabrication of multifunctional liposomes such as temperature-
sensitive liposomes [7], ganglioside- and sphingomyelin-modified
liposomes with long-term retention capability in blood [5], pH-
sensitive liposomes releasing encapsulated materials in endosomes
in a low pH environment [6], magnetic liposomes [8], and
ultrasound-sensitive liposomes [9].
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construct non-viral vectors that can effectively break through all
barriers in cells. For this, an individual non-viral vector should be
systematically packed with desired functional elements so that all
the elements work properly and effectively. Focusing on those
matters, Kogure et al. [10] introduced a novel non-viral vector
which consisted of a DNA-polycation condensate core and a lipid
bilayer membrane envelope surrounding the core. This kind of
non-viral vector, called a multifunctional envelope-type nanode-
vice (MEND), allows programmed packaging of various functional
elements into an individual nanostructured liposome. The core of
such a double-lamellar MEND (D-MEND) can accommodate
various gene therapy molecules, such as DNAs [10–15], siRNAs
[16–19] or proteins [20], as condensates with polycations. The
lipid bilayer membrane envelope of the MEND provides both
structural stability and topological control, and can be further
modified with functional elements, such as polyethylene glycols
[18,21], octaarginine [12–17], and transferrin [11], to enhance
intercellular trafficking. Akita et al. [22] have introduced a tetra-
lamellar MEND (T-MEND) that focused on efficient nuclear
membrane penetration. In their T-MEND, a DNA-polycation
condensate core was coated with two nuclear membrane-fusogenic
inner lipid envelopes and two endosome-fusogenic outer lipid
envelopes. Stepwise fusion of the two different lipid membranes
allowed highly efficient transgene expression in non-dividing cells.
Gene delivery by such MENDs has proven to be highly stable and
efficient [19,21,22], brightening up their future as non-viral
vectors.
Conventionally MENDs have been fabricated by wet chemistry-
based bulk batch methods such as lipid film hydration and
detergent-rich small unilamellar vesicle (SUV)-fusion [10–22],
with the latter method being more successful recently [11,22]. In
the vesicle formation process from micelles, detergent-rich SUVs
are temporarily formed by detergent removal and they can fuse
with each other to form large unilamellar vesicles by complete
removal of detergent [23]. The conventional fabrication methods
involve largely two different types of processes: the polycation-
induced condensation of nucleic acids (or proteins) and the
formation of one or more lipid bilayer membrane envelopes on
each condensate core. However, the conventional methods are
complicated, labor-intensive, and time-consuming, require rela-
tively large quantities of raw materials, and produce relatively
large amounts of waste. Furthermore, such bulk batch methods are
unsuitable for fabricating small quantities of diverse MENDs with
different functionalities in a short time, which is essential for their
effective application to order-made gene therapy.
Fabrication of MENDs using microfluidic chips can be an
excellent way for overcoming these problems because this lab-on-
a-chip approach allows utilization of the intrinsic merits of
microfluidic devices [24–29], such as their short reaction time,
high reaction efficiency, and low raw material consumption.
Previously we reported a seminal work on the application of
microfluidic chips to the fabrication of DNA-polycation conden-
sate cores and MENDs [30]. Plasmid DNA-ploy-L-lysine conden-
sate cores and MENDs were fabricated in a simple microfluidic
chip composed of three straight inlet channels and one straight
smooth reaction channel allowing diffusion-based precursor
mixing.
Unfortunately, fabrication of MENDs in the microfluidic chip
was unreliable. Particle size of the MENDs decreased as their
precursor flow rate increased and reproducibility of their
fabrication (i.e., their size and the size distribution) was poor.
These could be mainly attributed to the diffusion-based poor and
inconsistent mixing of their precursors in the smooth reaction
channel. Thus, for reliable on-chip fabrication of MENDs the
most reasonable but important approach is to use microfluidic
chips with novel designs that allow homogeneous precursor mixing
in a short time. A microfluidic chip with an array of bas-relief
structures on the floor of its reaction channel may be suitable for
this purpose [31]. Such a chaotic mixer array generates chaotic
flows in the reaction channel and that can lead to homogeneous
mixing of the precursor solutions in a short time.
Here, we report the reliable fabrication of D-MENDs using a
microfluidic chip that had an array of a staggered chaotic mixer
with bas-relief structures on the floor of its reaction channel. The
chaotic mixer array allowed homogeneous precursor mixing and
that led to reliable results in fabricating D-MENDs as well as D-
MENDs functionalized further with trans-membrane peptides
(Figure 1). Effects of the precursor flow rate on the size and zeta
potential of those non-viral vectors were also investigated. In
addition, the results from the on-chip fabrications were compared
with corresponding results from bulk batch fabrications.
Results and Discussion
Microfluidic Chips
Figure 2 shows schematic diagrams of a microfluidic chip and its
reaction channel with a chaotic mixer array. The chip, made of
polydimethylsiloxane (PMDS), was fabricated by a soft lithography
technique [32]. The design of the chaotic mixer array on the floor
of the reaction channel was slightly modified from that reported by
Stroock et al. [31]. As shown in Figure 2A, the chip consisted of a
long reaction channel (three lanes), two inlet channels, and one
outlet channel. The two inlet channels were connected to one end
of the reaction channel; the outlet channel was connected to the
other end of the reaction channel. The reaction channel had an
array of 69 cycles of the staggered chaotic mixer with two
sequential sets of herringbone structures. Each herringbone set
had six ridges and the direction of their asymmetry switched from
one set to the other. Details on the structural dimensions of the
chaotic mixer array are shown in Figure 2B: channel
height=75 mm; channel width=200 mm; ridge height=25 mm;
ridge width=50 mm; space between adjacent two ridges=50 mm.
The ridge height was fairly larger than that of ,17.7 mm for the
reference designs [31] and that might ensure better degree of
precursor mixing. The scanning electron microscopy (SEM)
images in Figure 2C confirm the staggered chaotic mixer array
Figure 1. Schematic representation of a D-MEND. It consists of a
condensed DNA/polycation core and a lipid bilayer membrane
envelope. Its surface is further modified with the membrane
penetrating peptide stearylated octaarginine to improve cellular uptake
and intracellular trafficking.
doi:10.1371/journal.pone.0039057.g001
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channel.
SUVs and Functional Nucleic Acid Cores
SUVs were prepared by drying a phospholipid solution of 1,2-
dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), cardiolipin
(CL), and chloroform, subsequently hydrating it using 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer,
then incubating the hydrated solution, and finally ultrasonically
treating it. The SUVs prepared in the bulk solution were analyzed
using dynamic light scattering (DLS). Figure 3 shows their particle
size distribution profile (red line). The fairly sharp large main peak
indicated the formation of SUVs with a fairly narrow particle size
distribution. Their average particle size and predominant particle
size (the particle size with strongest scattering intensity) were
estimated to be 104.8 nm and 81.1 nm, respectively: this size
difference was due to the presence of very large particles (i.e., 200–
1000 nm) formed together during the preparation. Their zeta
potential was measured as 244.6 mV. This highly negative f
value implied that the SUVs could favorably form complexes with
positively charged functional nucleic acid (f-NA) cores in
subsequent MEND fabrication. The size, size distribution, and f
value suggested that those SUVs might be suitable for use as a
MEND precursor.
f-NA cores were prepared by mixing a plasmid DNA (pcDNA-
DEST53 Gateway vector) solution and a protamine (protamine
sulfate, salmon milt) solution followed by forming the vortex and
incubating it at room temperature. Figure 3 also shows their
particle size distribution profile (blue line). The fairly sharp large
main peak suggested they were relatively small sized and with a
fairly narrow size distribution. Their average and predominant
particle sizes were estimated to be 102.3 nm and 81.1 nm,
respectively; this size difference could be attributed to the
contribution from the larger particles (i.e., 200–500 nm) formed
during the preparation. These sizes were within a typical size
range (72.32184 nm [15]) for DNA-polycation condensates used
for fabricating various MENDs that have been successfully applied
to gene transfection. Their zeta potential was measured as
+31.5 mV. This positive f value implied that the negatively
charged plasma DNAs and the positively charged protamins
interacted electrostatically to form the f-NAs. The DNAs with
relatively mild negative charge were easily condensed by the
protamines with strong positive charge (arginine content .70%)
and that resulted in the formation of f-NA cores with the net
positive f value. The size, size distribution, and f value suggested
that those f-NAs could be successfully used as a MEND precursor.
Mixing in the Chaotic Mixer Array
Confocal microscopy was employed to trace mixing of two
precursor solutions in the reaction channel. The rhodamine-
stained SUV solution and the f-NA core solution were introduced
simultaneously into separate inlets of the microfluidic chip using
microsyringe pumps and then fluorescence signals were observed
in various regions of the reaction channel. Figure 4 shows
fluorescence images for the precursor mixture solution flowing at
the rate of 10.0 mL min
21 in various regions of the staggered
chaotic mixer array. In the 0 cycle region (the smooth junction
region between the two inlet channels without bas-relief struc-
tures), we observed no solution mixing due to laminar flow of the
solutions. Fairly homogeneous fluorescence was observed in the
entire 10 cycle region. In the entire 15 cycle region, practically
homogeneous fluorescence was observed. Similar results were
obtained when using slower solution flow rates of 1.0 and
5.0 mL min
21 (data not shown). Higher flow rates were avoided
because they often led to poor reproducibility in the sizes and f
values of resulting particles. These results indicated homogeneous
mixing of the two precursor solutions in the early cycle region of
the chaotic mixer array and that confirmed high efficiency of the
chaotic mix array for the mixing of our MEND precursors.
Homogeneous mixing of the precursor solutions was further
confirmed by scanning along the z-direction in the 15 cycle
Figure 2. Structure of the microfluidic chip with a chaotic mixer
array. (A) Two-dimensional design of the chip: i1, an inlet for f-NA and
STR-R8; i2, an inlet for SUV and D-MEND; o1, an outlet. (B) Schematic
diagram of the staggered chaotic mixer: h1=75mm, w=200 mm,
h2=25mm, c=50 mm, s=50 mm. (C) SEM images of the parts of the
staggered chaotic mixers and herringbone ridges in the reaction
channel: 1506 (left) and 4506 (right). The SEM images show the
fabricated staggered chaotic mixer array and herringbone ridges.
doi:10.1371/journal.pone.0039057.g002 Figure 3. DLS particle size distribution profiles for SUVs and f-
NAs. The sharp main peak for the SUVs (red) indicates they were
formed with a narrow particle size distribution (daverage=104.8 nm,
dpredominant=81.1 nm). The sharp main peak for f-NAs (blue) suggests
they also had a narrow particle size distribution (daverage=102.3 nm,
dpredominant=81.1 nm).
doi:10.1371/journal.pone.0039057.g003
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showed substantially uniform fluorescence along the z-axis of the
reaction channel. All the above results suggested that the
microfluidic chip enabled efficient homogeneous mixing of the
precursor solutions and thus it could be used for MEND
fabrication.
The efficient homogeneous mixing in our microfluidic chip
could be mainly attributed to the chaotic mixer array on the floor
of the reaction channel. In general, mixing efficiency of
microfluidic chips can be characterized by the Pe ´clet number
(Pe) which is a measure of the relative rate of convective transport
to diffusive transport in fluid flows: a smaller Pe is more favorable
to mixing [31,33]. The Pe ´clet number is given as follows:
Pe=U6l/D where U is average flow speed, l is cross-sectional
dimension of the reaction channel, and D is a molecular diffusion
coefficient [31]. For the precursors (D ,1 mm
2 s
21 for liposomes
with d ,1002200 nm [34236]) flowing at 10 mL min
21 in our
microfluidic chip (l=122.5 mm), Pe is , 1.36 6 10
6. This very
large Pe indicates predominance of uniaxial flow which is
unfavorable for mixing. In a simple smooth microchannel
(height=75 mm, width=200 mm) for which the cross-sectional
dimension is the same as that for our reaction channel, the
distance along the channel required for mixing to occur (the
mixing length, Dy , Pe6l [31]) is then ,16700 cm. This very long
mixing length implies that homogeneous mixing in the smooth
microchannel requires very long reaction channel lengths. It will
be extremely difficult to achieve homogeneous mixing in such a
smooth reaction channel. However, in a microchannel with steady
chaotic flow and high Pe, like in our reaction channel, the mixing
length is defined as follows: Dy , l6lnPe where l is a
characteristic length determined by the geometry of trajectories
in the chaotic flow [31]. Previously l of ,0.1 cm (0.0820.13 cm,
90% mixing [31]) was reported for the microchannel with a
chaotic mixer array with a structure that was very similar to our
reaction channel structure. Thus, in our reaction channel with the
chaotic mixer array, the mixing length for 90% mixing (Dy90)a t
the flow rate of 10.0 mL min
21 was , 1.41 cm. This very small
Dy90 suggested that a short length of the reaction channel might be
enough to achieve homogeneous mixing.
Table 1 summarizes Pe ´clet numbers and mixing lengths at the
flow rates used in the experiments. In the flow rate range
investigated, the Pe ´clet numbers are very large. In such uniaxial
flow conditions, extremely long lengths of smooth microchannels
are required for achieving homogeneous mixing. In the smooth
microchannel, the mixing length at the flow rate of 1 mL min
21 is
1670 cm and it increases linearly and sharply with increasing the
flow rate. This observation indicates that increasing the flow rate
in the smooth microchannel makes the mixing much more
difficult. However, in our reaction channel with the chaotic mixer
array, the mixing lengths were very small (1.1821.41 cm),
although the length increased slightly with increasing flow rate.
The much reduced, small mixing lengths for our reaction channel,
as compared with those for the smooth microchannel, suggested
that the chaotic mixer array of the reaction channel was
responsible for the observed efficient homogeneous mixing.
D-MENDs
D-MENDs were fabricated in the reaction channel of the
microfluidic chip by introducing the f-NA core solution and the
SUV solution into separate inlets and then they were analyzed
using DLS. Various precursor flow rates were employed to
investigate their effects on the size, size distribution, and f of
resulting D-MENDs. In addition, D-MENDs were also fabricated
by the bulk SUV-fusion method. The bulk batch-fabricated D-
MENDs were analyzed using DLS for comparison with the results
from the on-chip-fabricated D-MENDs.
Figure 5 shows the average particle sizes (blue circles) and the
predominant particle sizes (wine red stars) for the on-chip-
fabricated D-MENDs at different precursor flow rates (see Figure
S1, for corresponding DLS particle size distribution profiles) and
Table 2 summarizes the results. The average particle sizes for the
on-chip-fabricated D-MENDs were very similar to each other
(117.32123.2 nm) regardless of the flow rates. The average
particle sizes for the D-MENDs were slightly larger than those for
their precursors (SUVs=104.8 nm, f-NA core=102.3 nm) but
very similar to the average size of 119.1 nm for the bulk batch-
fabricated D-MENDs. In addition, the predominant particle size
for the on-chip-fabricated D-MENDs was independent of their
precursor flow rate. Their predominant particle size was
100.0 nm regardless of the flow rates, indicating that the majority
of the on-chip-fabricated D-MENDs had a particle size of
100.0 nm. The differences between the average and predominant
sizes could be ascribed to the partial destruction of D-MENDs
followed by their combination. During on-chip fabrication, some
of the initial formed D-MENDs could be partially destructed due
to their collision onto the rough bas-relief structures on the floor of
Figure 4. Fluorescence images tracing the progress of the
MEND precursor mixing in the microchannel. The rhodamine-
stained SUV solution and the f-NA solution were mixed in the
microchannel and fluorescence images (xy-plane) were recorded using
a confocal microscope in (A) 0, (B) 1, (C) 5, (D) 10, and (E) 15 cycle
regions of the chaotic mixer array. (F) Accumulated scanned
fluorescence images along the z-axis direction in the 15 cycle region.
(G) Image (xy-plane) of the 15 cycle region before precursor
introduction. Flow rate=10.0 mlm i n
21.S c a l eb a r s = 3 0 0 mm. The
fluorescence images indicate homogeneous mixing of the two
precursor solutions in the early cycle region of the chaotic mixer array.
doi:10.1371/journal.pone.0039057.g004
Table 1. The Pe ´clet numbers and the mixing lengths in the
microchannels (height=75 mm, width=200 mm) with and
without the chaotic mixer array.
Flow rate (mLm i n
21)13571 0
Flow speed (cm s
21) 0.111 0.333 0.556 0.778 1.111
10
256Pe
a 1.36 4.08 6.81 9.53 13.6
Dy, smooth (cm)
b 1670 5000 8340 11700 16700
Dy90, chaotic (cm)
c 1.18 1.29 1.34 1.38 1.41
aPe ´clet number calculated taking D=1mm
2 s
21.
bMixing length in the smooth microchannel.
cMixing length in the microchannel with the chaotic mixer array.
doi:10.1371/journal.pone.0039057.t001
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one or more of the intact D-MENDs or the partially destructed D-
MENDs and that could result in larger-than-average-sized D-
MENDs. The faster and stronger collisions (i.e., higher flow rates)
might lead to more formation of much larger-than-average-sized
D-MENDs. These observations on the particle sizes suggested
relatively fast formation of D-MENDs with stable structures in the
reaction channel. Previously use of a microfluidic chip with a
simple smooth reaction channel (channel length=5.25 cm) led to
the fabrication of D-MENDs for which particle size decreased
with increasing their precursor flow rate from 1.0 to 10 mL min
21
[30]. This flow rate-dependent particle size change and the mixing
lengths summarized in Table 1 suggest that the smooth reaction
channel is unsuitable for the reliable fabrication of MENDs
because a complete mixing of the precursors in such a channel
requires very long channel lengths. Thus, the formation of similar-
sized D-MENDs in our microfluidic chip at the very different
precursor flow rates could be ascribed to the chaotic mixer array
on the floor of the chip reaction channel. The chaotic mixer array
led to very short mixing lengths (Table 1) and that ensured
homogeneous mixing of the MEND precursor solutions in its early
cycle region (i.e., in a short time) and hence the formation of the
D-MENDs with stable structures.
Zeta potential, like the average particle size, for the on-chip-
fabricated D-MENDs was little affected by their precursor flow
rate, as shown in Figure 5 (red squares). Their f values (between
244.5 and 250.1 mV) were very similar to each other regardless
of the flow rates (Table 2). The f values were very similar to the f
value of 244.2 mV for the bulk batch-fabricated D-MENDs.
These results indicated that the electrical charge structure on the
surface of the on-chip fabricated D-MENDs was very similar to
that of the bulk batch-fabricated D-MENDs.
The particle size and zeta potential observations we described
above manifested the on-chip fabrication of the D-MEND
composed of the f-NA core and the lipid bilayer membrane
envelope. The highly negative f values which were similar to each
other and the slightly increased particle sizes after the fabrication
of the D-MENDs starting from f-NA cores implied that the
positively charged f-NA core was encapsulated in the negatively
charged lipid bilayer membrane envelope. Both the particle size
and the electrical charge structure on the surface of the D-MENDs
were slightly dependent on the fabrication methods and the
precursor flow rates. The on-chip fabrication of the D-MENDs
took about 10 min which was much faster than their bulk batch
fabrication typically requiring about one day. The overall results
here indicated that the microfluidic chip with the chaotic mixer
array could be used for the fast, convenient, reliable fabrication of
D-MENDs with a size and surface charge structure very similar to
the size and charge structure of the bulk batch-fabricated D-
MENDs.
R8-MENDs
R8-MENDs were fabricated in the microfluidic chip to
investigate the possibility for fast, convenient incorporation of
additional functionalities onto D-MENDs. Stearylated octaargi-
nine (STR-R8, a trans-membrane peptide) and the bulk batch-
fabricated D-MENDs were concurrently introduced into the
reaction channel through the respective inlets and that led to the
addition of STR-R8 moieties on the phospholipid bilayer of the D-
MENDs. Like the D-MEND fabrication, the on-chip fabrication
of the R8-MENDs took about 10 min whereas their bulk batch
fabrication took about one day.
Figure 6 shows the dependences of the average particle size
(blue circles) and the predominant particle size (wine red stars) for
the R8-MENDs on their precursor flow rate in the reaction
channel (see Figure S2 in SI for corresponding DLS particle size
distribution profiles) and Table 2 summarizes the results. The
average particle size of the R8-MENDs fabricated at the flow rate
of 3 mL min
21 was slightly larger than the 119.1 nm size for their
precursor D-MENDs. However, the average particle size of the
on-chip-fabricated R8-MENDs became larger as the flow rate
increased. Interestingly their predominant particle size was
independent of the precursor flow rate and was 100.0 nm
regardless of the rate. The predominant particle size was slightly
larger than of the 81.1 nm size for their precursor D-MENDs. In
our bulk and on-chip fabrication conditions, the predominant
particle sizes of the D- and R8-MENDs were always smaller than
the average particle sizes of the corresponding MENDs.
Figure 6 also shows the dependence of zeta potential (red
squares) for the R8-MENDs on their precursor flow rate. Zeta
potential values for the on-chip-fabricated R8-MENDs were
highly positive (between +47.1 and +52.6 mV, Table 2) and they
were influenced only slightly by the precursor flow rates. The f
values for the on-chip-fabricated R8-MENDs were very similar to
Figure 5. Precursor flow rate-dependent changes in the
particle size and zeta potential of the D-MENDs. Both the
average particle size (blue circles) and predominant particle size (wine
red stars) of the D-MENDs depended only slightly on their precursor
flow rate. Their zeta potential values (red squares) were highly negative
due to their negatively charged lipid bilayer membrane envelope.
doi:10.1371/journal.pone.0039057.g005
Table 2. Average particle size, predominant particle size, and
zeta potential of the D-MENDs and R8-MENDs.
Flow rate (mLm i n
21) Bulk
a 35 71 0
daverage, D-MEND (nm) 119.1 123.2 117.3 119.5 121.6
dpredominant, D-MEND (nm) 81.1 100.0 100.0 100.0 100.0
fD-MEND (mV) 244.2 244.5 250.1 248.7 246.1
daverage, R8-MEND (nm) 179.5 136.1 172.0 193.5 224.2
dpredominant, R8-MEND (nm) 152.0 100.0 100.0 100.0 100.0
fR8-MEND (mV) +45.0 +49.1 +50.1 +52.6 +47.1
aData for the MENDs fabricated by the bulk SUV-fusion method.
doi:10.1371/journal.pone.0039057.t002
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indicated that the electrical charge structure on the surface of the
on-chip-fabricated R8-MENDs was very similar to that of the bulk
batch-fabricated R8-MENDs.
Our above observations on the particle sizes and zeta potential
could be interpreted as follows. Both the average particle sizes and
the predominant particle sizes for the on-chip-fabricated R8-
MENDs were larger than corresponding sizes for their precursor
D-MENDs, like the cases for the bulk batch-fabricated R8-
MENDs. In addition, zeta potential changed from the highly
negative values to highly positive values as the precursor D-
MENDs were transformed to the R8-MENDs. These results
implied that the mixing of the STR-R8 and D-MEND precursors
in the reaction channel led to the successful formation of R8-
MENDs having a surface covered by positively charged STR-R8.
For the on-chip-fabricated R8-MENDs, the predominant particle
size was 100.0 nm regardless of the precursor flow rate. This fact
suggested that the majority of them had a particle size of
100.0 nm. The fact further indicated that the R8-MENDs with a
particle size of 100.0 nm were the most stable R8-MEND species
formed in our on-chip fabrication conditions. The observed flow
rate-dependence of the predominant particle size contradicted to
the flow rate-dependence of the average particle size. For on-chip-
fabricated R8-MENDs, their average particle size became larger
with increasing precursor flow rate. This trend for their average
particle size could be attributed to the enhanced contribution from
larger-than-average-sized R8-MENDs (see Figure S2 in SI for the
corresponding DLS particle size distribution profiles). During on-
chip fabrication of the R8-MENDs, their precursors would collide
many times onto the rough bas-relief structures and the collisions
became faster and stronger as the precursor flow rate increased.
The collisions might naturally lead to partial destruction of the
lipid bilayer membrane envelopes of the precursor D-MENDs and
that resulted in the formation of partially destructed D-MENDs.
In the reaction channel, larger sized R8-MENDs could be formed
by the combination of two or more of the partially destructed D-
MENDs with appropriate numbers of STR-R8. In addition, some
of the initially formed R8-MENDs could collide onto the bas-relief
structures and that might lead to the formation of partially
destructed R8-MENDs. One or more of the partially destructed
R8-MENDs could combine with one or more of the partially
destructed D-MEND or R8-MENDs in the reaction channel and
that subsequently led to larger-than-average-sized R8-MENDs.
The faster and stronger collisions might lead to more formation of
much larger-than-average-sized R8-MENDs. Thus, it might be
highly desirable to use low precursor flow rates (i.e., #
5 mL min
21) when fabricating R8-MENDs because low precursor
flow rates were seen as highly beneficial to the fabrication of R8-
MENDs with a narrow particle size distribution. Interestingly, the
predominant particle size for the on-chip-fabricated R8-MENDs
was much smaller than that for the bulk batch-fabricated R8-
MENDs and their smaller particle size could be highly beneficial
to their cell membrane penetration.
The overall results here indicated that the microfluidic chip with
the chaotic mixer array in its reaction channel allowed for the
convenient, fast, reliable fabrication of R8-MENDs having a size
and surface charge structure comparable to or better than those of
the R8-MENDs fabricated by the time-consuming, inconvenient
bulk SUV-fusion method.
In conclusion, we successfully fabricated MENDs using a
PDMS microfluidic chip with a chaotic mixer array in its reaction
channel and then investigated their physical properties. The
presence of the chaotic mixer array on the floor of the reaction
channel dramatically reduced the mixing length in spite of very
large Pe (.10
5 at 1210 mL min
21) favoring laminar flow. Their
mixing lengths (,1.5 cm) were more than 1000 times smaller than
those for the corresponding smooth reaction channel. The chaotic
mixer array allowed homogeneous mixing of the precursor
solutions in a short time (10–20 min) and that led to fast,
convenient, reliable fabrication of D-MENDs as well as further
functionalized R8-MENDs. Mixing of the phospholipid SUVs and
the f-NAs in the microfluidic chip resulted in D-MENDs
composed of a condensed plasmid DNA core and a lipid bilayer
membrane envelope encapsulating the core. Their surface was
strongly negatively charged due to the lipids. Similarly, mixing of
trans-membrane peptide STR-R8 molecules and the D-MENDs
in the microfluidic chip led to R8-MENDs in which STR-R8
moieties were added on the phospholipid bilayer of the D-
MENDs. The MENDs were strongly positively charged due to the
R8 moieties on their surface. The sizes and surface charge
structures of the on-chip-fabricated MENDs were comparable to
or better than those of the bulk batch-fabricated counterparts.
Biological activities of those MENDs will be characterized in
subsequent studies. Our results should greatly contribute to the
development of fast, simple, convenient, economical, and reliable
methods for fabricating various kinds of elegant liposome-based
non-viral vectors that are suitable for practical gene therapy
applications.
Materials and Methods
Materials
Acetone, isopropanol, chloroform, and ethanol were purchased
from Wako Pure Chemical Industries (Japan). CL and trichlor-
o(1H,1H,2H,2H-perfluorooctyl)silane were acquired from Sigma-
Aldrich (USA). Silpot 184 and its catalyst were obtained from Dow
Corning Toray (Japan). Protamine sulfate (from salmon milt) was
obtained from Calbiochem (USA). HEPES buffer solution
(10 mM, pH 7.4) was purchase from Dojindo (Japan). pcDNA-
Figure 6. Precursor flow rate-dependent changes in the
particle size and zeta potential of the R8-MENDs. As the
precursor flow rate increased, their average particle size (blue circles)
increased whereas their predominant particle size (wine red starts did
not change. Their zeta potential values (red squares) were highly
positive due to the presence of the positively charged STR-R8 on their
surface.
doi:10.1371/journal.pone.0039057.g006
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STR-R8 was obtained from Kurabo Industries (Japan). DOPE
and 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(lissa-
mine rhodamine B sulfonyl) (ammonium salt) (18:1 Liss Rhod
PE, Rho-DOPE) were acquired from Avanti Polar Lipids (USA).
SU-8 3050 and SU-8 developer were purchased from Microchem
(Japan).
Microfluidic Chip Fabrication
Microfluidic chips made of PMDS were fabricated using a soft
lithography technique [32]. The design of their chaotic mixer
array was adopted from that reported by Stroock et al. [31] after
slight modifications. The most distinctive difference in the designs
was in the height of herringbone ridges. We adopted much deeper
ridges (25 mm vs. ,17.7 mm for the reference designs [31]) to
ensure better degree of precursor mixing.
A microfluidic chip master was fabricated as follows. First, a
mirror-finished, 3-inch Si-wafer (Cretec Industry, Japan) was
washed with acetone and isopropanol. The washed Si-wafer was
placed on a hot plate and heated at 200uC for 5 min. After that,
the wafer was placed on the rotor of a spin-coater (IH-D7, Mikasa,
Japan) and then spin-coated (conditions: Slope 5 s, 500 rpm 5 s;
Slope 8 s, 3000 rpm 45 s) with a photo-resist chemical SU-8 3050.
After completing the spin-coating, the wafer was placed on the
hotplate and heated at 95uC for 10 min. After cooling down to
room temperature, the photo-resist chemical-coated wafer was
masked with a transparency film printed with a microfluidic
channel shape (Nagoya University Coop, Japan). After that, the
photo-resist chemical was cured by exposing it to ultraviolet light
for 15 s using photolithography equipment (MJB3, Karl Suss,
Germany). After curing, the wafer was placed on the hotplate and
heated at 95uC for 8 min. After that, the coated chemical was
developed in Su-8 developer solution. Finally, the fabricated chip-
master was washed thoroughly with isopropanol and its surface
was silanized using trichloro(1H,1H,2H,2H-perfluorooctyl)silane.
A PDMS microfluidic chip was fabricated as follows. The
silanized chip-master was placed in a Petri dish on a hot plate.
PDMS precursor (Silpot 184, Dow Corning Toray, Japan) and its
cross-linker were weighed (10:1 weight ratio) separately and then
mixed in a beaker. The mixture was then poured onto the Petri
dish. After that, the dish was heated at 90uC for 2 h. After cooling
down to room temperature, the fabricated PDMS structure was
removed from the chip-master and then trimmed into a
rectangular shape (,76 mm6,52 mm). The trimmed PDMS
structure was punched to make inlet and outlet holes. Finally, the
PDMS structure was attached on a slide glass (76 mm652 mm,
Matsunami Glass, Japan) to construct a microfluidic chip.
f-NA and SUV Fabrication
A f-NA core solution was prepared by mixing plasmid DNA
solution (0.10 mg mL
21) and 75 mL of 10 mM HEPES buffer
solution containing protamine sulfate (0.10 mg mL
21) followed by
forming the vortex for 30 s and incubating it at room temperature
for 15 min. Electrostatic interaction between the negatively
charged plasmid DNAs and the polycationic nuclear proteins led
to the formation of their compact agglomerates called f-NAs.
SUVs were prepared as follows. First, a phospholipid solution
was prepared by mixing 20 mL of DOPE in chloroform
(20 mg mL
21), 165 mL of CL in ethanol (5 mg mL
21), and
165 mL of chloroform. After that, the solution was transferred to a
brown test tube and dried by blowing nitrogen gas. After drying,
165 mL of chloroform was dropped into the test tube, dried by
blowing nitrogen gas over the liquid surface, and then further
dried under vacuum for 30 min in the dark. After drying was
completed, 1 mL of 10 mM HEPES buffer (pH 7.4) was added
and then the solution was incubated for 10 min at room
temperature for sufficient hydration. After completing hydration,
the solution was ultrasonically treated for 5 min, using a vortex-
type sonicator (UH-50, SMT Inc., Japan), to complete the SUV
preparation. Rhodamine-stained SUVs were prepared by follow-
ing the same procedures for preparing SUVs described above
except for using a phospholipid solution containing 20 mLo f
DOPE in chloroform (20 mg mL
21), 165 mL of CL in ethanol
(5 mg mL
21), 41 mL of Rho-DOPE in chloroform
(0.01 mg mL
21), and 165 mL of chloroform.
Bulk Fabrication of MENDs
D-MENDs were fabricated by mixing 250 mL of the SUV
solution and 125 mL of the f-NA core solution followed by forming
the vortex and incubating it for 15 min at room temperature.
Rhodamine-stained D-MENDs were fabricated by mixing 250 mL
of the rhodamine-stained SUV solution and 125 mL of the f-NA
core solution followed by forming the vortex and incubating it for
15 min at room temperature. D-MENDs with an additional
functionality (R8-MEND) were fabricated by adding STR-R8 in
HEPES buffer solution (2 mg ml
21)( ,20 mol % of the total lipid
content) into the bulk batch-fabricated D-MEND solution
followed by forming the vortex and incubating it for 15 min at
room temperature.
On-chip Fabrication of MENDs
D-MENDs were fabricated in the microfluidic chip by
introducing the SUV solution and the f-NA core solution into
separate inlets using microsyringe pumps. Flow rates of the two
precursor solutions employed were 3, 5, 7, and 10 mL min
21.I n
each fabrication, the same flow rate was employed for the two
precursor solutions. R8-MENDs were fabricated in the micro-
fluidic chip by introducing the bulk batch-fabricated D-MEND
solution and the STR-R8 in HEPES buffer solution (2 mg mL
21)
into respective inlets using microsyringe pumps. Flow rates of 3, 5,
7, and 10 mL min
21 were employed for the fabrication. In each
fabrication, the same flow rate was employed for the two precursor
solutions.
Characterization
SEM images were obtained with a scanning electron micro-
scope (S-4300, Hitachi, Japan) to observe the structure of the
microfluidic chips. The surface of the chip was sputtered with gold
for SEM observations. DLS measurements were done with a
dynamic light scattering photometer (ELS-Z, Otsuka Electronics,
Japan) to estimate size distribution and zeta potential of sample
particles. Confocal microscopy measurements were done with a
confocal laser scanning biological microscope system (Fluoview
FV1000, Olympus, Japan).
Supporting Information
Figure S1 DLS particle size distribution profiles for D-
MENDs fabricated at various precursor flow rates in the
microfluidic chip with a chaotic mixer array. The profile
for D-MENDs fabricated by the bulk SUV fusion method is also
included.
(DOCX)
Figure S2 DLS particle size distribution profiles for R8-
MENDs fabricated at various precursor flow rates in the
microfluidic chip with a chaotic mixer array. The profile
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included.
(DOCX)
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